FindMyKOL
Clinical trialNCT02651259CompletedPhase 1/PHASE2Interventional

Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment50Tuberculosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study was to evaluate the pharmacokinetics (PK), tolerability, and safety of once-weekly doses of rifapentine (RPT) and isoniazid (INH) in HIV-1-infected and HIV-1-uninfected pregnant and postpartum women with latent tuberculosis (TB).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Haiti
  • Les Centres Gheskio Clinical Research Site (gheskio-Inlr) Crs

    Port-au-Prince, Haiti

Kenya
  • Kenya Medical Research Institute / Walter Reed Project Clinical Research Center, Kericho Crs

    Kericho, Kenya

Malawi
  • Malawi Crs

    Lilongwe, Central Malawi, Malawi

Thailand
  • Siriraj Hospital ,mahidol University Nichd Crs

    Bangkok, Bangkoknoi, Thailand

Zimbabwe
  • Harare Family Care Crs

    Harare, Zimbabwe

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Isoniazid →Rifapentine →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Mar 2017
Primary completion
10 Apr 2019
Completion
10 Apr 2019
Last update posted
4 Nov 2021
Registered enrollment
50
Registry id
NCT02651259
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.